Consolidated Statements of Stockholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Treasury Stock, at Cost	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Stockholders’ Equity	Noncontrolling Interest
Beginning balance (in shares) at Jan. 31, 2021		65,098,379
Beginning balance at Jan. 31, 2021	$ 698,953	$ 785	$ (438,798)	$ 473,728	$ 671,196	$ (8,168)	$ 698,743	$ 210
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	90,854				90,860		90,860	(6)
Other comprehensive income (loss)	1,370					1,370	1,370
Share-based compensation	37,819			37,819			37,819
Repurchase of common stock (in shares)		(1,387,624)
Repurchase of common stock	(97,000)		(97,000)				(97,000)
Treasury stock reissued (in shares)		688,486
Treasury stock reissued	(13,598)		16,188	(29,786)			(13,598)
Ending balance (in shares) at Oct. 31, 2021		64,399,241
Ending balance at Oct. 31, 2021	718,398	$ 785	(519,610)	481,761	762,056	(6,798)	718,194	204
Beginning balance (in shares) at Aug. 01, 2021		64,396,741
Beginning balance at Aug. 01, 2021	708,623	$ 785	(499,199)	486,693	727,629	(7,491)	708,417	206
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	34,425				34,427		34,427	(2)
Other comprehensive income (loss)	693					693	693
Share-based compensation	13,289			13,289			13,289
Repurchase of common stock (in shares)		(387,163)
Repurchase of common stock	(30,000)		(30,000)				(30,000)
Treasury stock reissued (in shares)		389,663
Treasury stock reissued	(8,632)		9,589	(18,221)			(8,632)
Ending balance (in shares) at Oct. 31, 2021		64,399,241
Ending balance at Oct. 31, 2021	$ 718,398	$ 785	(519,610)	481,761	762,056	(6,798)	718,194	204
Beginning balance (in shares) at Jan. 30, 2022	64,098,565	64,098,565
Beginning balance at Jan. 30, 2022	$ 737,775	$ 785	(549,942)	491,956	796,860	(2,075)	737,584	191
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	112,387				112,393		112,393	(6)
Other comprehensive income (loss)	1,504					1,504	1,504
Sale of warrants (see Note 9)	42,909			42,909			42,909
Purchase of convertible note hedge (see Note 9)	(72,559)			(72,559)			(72,559)
Share-based compensation	33,727			33,727			33,727
Repurchase of common stock (in shares)		(762,093)
Repurchase of common stock	(50,000)		(50,000)				(50,000)
Treasury stock reissued (in shares)		501,257
Treasury stock reissued	$ (13,146)		20,674	(33,820)			(13,146)
Ending balance (in shares) at Oct. 30, 2022	63,837,729	63,837,729
Ending balance at Oct. 30, 2022	$ 792,597	$ 785	(579,268)	462,213	909,253	(571)	792,412	185
Beginning balance (in shares) at Jul. 31, 2022		63,516,341
Beginning balance at Jul. 31, 2022	799,046	$ 785	(594,449)	506,178	886,507	(163)	798,858	188
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	22,743				22,746		22,746	(3)
Other comprehensive income (loss)	(408)					(408)	(408)
Sale of warrants (see Note 9)	42,909			42,909			42,909
Purchase of convertible note hedge (see Note 9)	(72,559)			(72,559)			(72,559)
Share-based compensation	9,016			9,016			9,016
Treasury stock reissued (in shares)		321,388
Treasury stock reissued	$ (8,150)		15,181	(23,331)			(8,150)
Ending balance (in shares) at Oct. 30, 2022	63,837,729	63,837,729
Ending balance at Oct. 30, 2022	$ 792,597	$ 785	$ (579,268)	$ 462,213	$ 909,253	$ (571)	$ 792,412	$ 185